GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sona Nanotech Inc (XCNQ:SONA) » Definitions » Cyclically Adjusted Price-to-FCF

Sona Nanotech (XCNQ:SONA) Cyclically Adjusted Price-to-FCF : (As of Jun. 06, 2025)


View and export this data going back to 2006. Start your Free Trial

What is Sona Nanotech Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Sona Nanotech Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Sona Nanotech's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sona Nanotech Cyclically Adjusted Price-to-FCF Chart

Sona Nanotech Annual Data
Trend Oct14 Oct15 Oct16 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sona Nanotech Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sona Nanotech's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Sona Nanotech's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sona Nanotech's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sona Nanotech's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sona Nanotech's Cyclically Adjusted Price-to-FCF falls into.


;
;

Sona Nanotech Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Sona Nanotech's Cyclically Adjusted FCF per Share for the quarter that ended in Jan. 2025 is calculated as:

For example, Sona Nanotech's adjusted Free Cash Flow per Share data for the three months ended in Jan. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jan. 2025 (Change)*Current CPI (Jan. 2025)
=-0.004/127.4427*127.4427
=-0.004

Current CPI (Jan. 2025) = 127.4427.

Sona Nanotech Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201501 -0.002 98.209 -0.003
201504 -0.004 99.710 -0.005
201507 -0.006 100.579 -0.008
201510 0.000 100.500 0.000
201601 -0.002 100.184 -0.003
201604 0.000 101.370 0.000
201607 -0.001 101.844 -0.001
201610 -0.001 102.002 -0.001
201701 -0.001 102.318 -0.001
201704 -0.001 103.029 -0.001
201707 0.001 103.029 0.001
201801 -0.023 104.056 -0.028
201804 -0.005 105.320 -0.006
201807 0.004 106.110 0.005
201810 -0.028 105.952 -0.034
201901 -0.014 105.557 -0.017
201904 -0.007 107.453 -0.008
201907 -0.007 108.243 -0.008
201910 -0.001 107.927 -0.001
202001 -0.006 108.085 -0.007
202004 -0.013 107.216 -0.015
202007 -0.044 108.401 -0.052
202010 -0.016 108.638 -0.019
202101 -0.018 109.192 -0.021
202104 -0.010 110.851 -0.011
202107 -0.019 112.431 -0.022
202110 -0.013 113.695 -0.015
202201 -0.008 114.801 -0.009
202204 -0.007 118.357 -0.008
202207 -0.007 120.964 -0.007
202210 -0.004 121.517 -0.004
202301 -0.001 121.596 -0.001
202304 -0.007 123.571 -0.007
202307 -0.005 124.914 -0.005
202310 -0.002 125.310 -0.002
202401 -0.007 125.072 -0.007
202404 -0.001 126.890 -0.001
202407 0.000 128.075 0.000
202410 -0.011 127.838 -0.011
202501 -0.004 127.443 -0.004

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sona Nanotech  (XCNQ:SONA) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Sona Nanotech Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Sona Nanotech's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sona Nanotech Business Description

Traded in Other Exchanges
Address
1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and various biomedical applications. The company's product includes Gemini and Saliva tests.

Sona Nanotech Headlines

No Headlines